Mutation leads to combined hyperlipidemia; genetic targeting may reverse it

February 5, 2014 by Helen Dodson
Mutation leads to combined hyperlipidemia; genetic targeting may reverse it
Credit: Shutterstock

(Medical Xpress)—A Yale study has identified the underlying genetic basis of combined hyperlipidemia, as well as a treatment that may normalize the condition. The study appears in Cell Metabolism.

Combined is characterized by high plasma levels of triglycerides and LDL cholesterol. The disorder is a major risk factor for atherosclerosis of the coronary artery, , and other small and large arteries, leading to heart attack, stroke and limb ischemia.

Until now, very little has been known about the underlying mechanism of combined hyperlipidemia, and no single gene has been clearly linked to the disorder. The Yale researchers focused on the LRP6 gene and the effect of its mutation in mice. The mutation, which was first identified in humans with early onset and combined hyperlipidemia, causes a cascade of events in diverse signaling pathways that results in abnormally elevated levels of LDL and triglycerides.

In this study the investigators found that the abnormality in the Wnt signaling pathway affects the function of a transcription factor widely known for its association with diabetes and elevated . They further found that rescuing this pathway normalizes the expression of enzymes regulating plasma lipids and restores normal LDL and triglyceride levels.

A number of studies had previously shown direct or indirect association between Wnt signaling pathway and its coreceptor LRP6, and hyperlipidemia in humans. "Our finding basically establishes the link between them, and most importantly demonstrates that the hyperlipidemia can be rescued by normalization of this pathway," said senior author Arya Mani of the Yale Cardiovascular Research Center.

"Our study opens the way for potential development of novel therapeutics for treating hyperlipidemia, and a favorable outcome for coronary artery disease or survival," she added.

Explore further: Experts recommend screening adults for hypertriglyceridemia every five years

More information: Gwang-woong Go, Roshni Srivastava, Antonio Hernandez-Ono, Gyoungok Gang, Stephen B. Smith, Carmen J. Booth, Henry N. Ginsberg, Arya Mani. "The Combined Hyperlipidemia Caused by Impaired Wnt-LRP6 Signaling Is Reversed by Wnt3a Rescue." Cell Metabolism, Volume 19, Issue 2, 209-220, 4 February 2014. 10.1016/j.cmet.2013.11.023

Related Stories

Experts recommend screening adults for hypertriglyceridemia every five years

September 7, 2012
The Endocrine Society today issued a Clinical Practice Guideline (CPG) for the diagnosis and treatment of hypertriglyceridemia. Triglycerides are a type of fat found in the blood and are associated with cardiovascular risk. ...

Prognostic value of lipoprotein (a) with low cholesterol unclear

November 22, 2013
(HealthDay)—Lipoprotein (a) (Lp[a]) has utility in assessing cardiovascular risk in patients with coronary artery disease (CAD); however, the prognostic value of Lp(a) in patients with low cholesterol levels remains unclear, ...

How 'bad' cholesterol causes atherosclerosis in humans: Stem cells play a key role

September 23, 2013
University at Buffalo translational researchers are developing a richer understanding of atherosclerosis in humans, revealing a key role for stem cells that promote inflammation.

Recommended for you

The 16 genetic markers that can cut a life story short

July 27, 2017
The answer to how long each of us will live is partly encoded in our genome. Researchers have identified 16 genetic markers associated with a decreased lifespan, including 14 new to science. This is the largest set of markers ...

A rogue gene is causing seizures in babies—here's how scientists wants to stop it

July 26, 2017
Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for answers and better treatment options.

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.